Company profile: Appletree CI
1.1 - Company Overview
Company description
- Provider of specialized CRO and CSO services in ophthalmology and medical device investigations, offering global regulatory affairs and end-to-end clinical development solutions, flexible functional service outsourcing, real-world evidence and virtual studies, advisory and talent support, and strategic resourcing across 11 European nations.
Products and services
- Real World Evidence: Conducts non-interventional and late-phase studies using diverse data sources and methodologies to produce stakeholder-required outcomes and evidence for decision-making
- Clinical Development: Architects early-phase planning and regulatory strategy through clinical operations to post-authorization studies and real-world evidence, streamlining trials and compliance across development
- Functional Services (FSP): Supplies flexible, scalable outsourcing models for clinical workforce management, covering clinical monitoring, data management, drug safety, medical writing, and project management.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Appletree CI
Icagen
HQ: United States
Website
- Description: Provider of ion channel-focused drug discovery platforms and services, including the Ion Channel Technology combining novel reagent generation, advanced biophysical analysis, and in silico tools; discovery-to-lead optimization services; and partnering with pharma/biotech to advance orally administered small-molecule therapeutics in neuroscience and chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Icagen company profile →
Prothya Biosolutions
HQ: Belgium
Website
- Description: Provider of plasma protein therapeutics and services, including immunoglobulin for primary/secondary immunodeficiency and neuromuscular disorders (MMN, CIDP); albumin for blood loss, burns, and sepsis; prothrombin complex and Cofact for coagulation disorders. Offers product/process development (viral safety, formulations, stability, characterization) and contract manufacturing of plasma intermediates, APIs, drug substances, and final products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prothya Biosolutions company profile →
MedPharm
HQ: United Kingdom
Website
- Description: Provider of topical and transdermal product design and formulation development services, offering unique, cost-effective performance testing models to reduce risk and accelerate development for generic and proprietary pharmaceutical customers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedPharm company profile →
Prolaio
HQ: United States
Website
- Description: Provider of prescriptive analytics-driven HealthTech solutions for continuous cardiac monitoring and risk assessment, including post-discharge heart failure and hypertrophic cardiomyopathy systems, AI-powered predictive analytics for care teams, remote monitoring for clinical studies, and a patient app for data collection, guidance, and reporting to support early intervention and reduce readmissions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prolaio company profile →
NorthX Biologics
HQ: Sweden
Website
- Description: Provider of contract development and manufacturing services for biologics from concept to commercial manufacturing; process development upstream/downstream optimization and verification; biopharmaceutical testing (analytical development, method validation, stability); recombinant protein production (microbial and mammalian); viral vector and vaccine development/manufacturing for clinical and commercial stages; GMP/non-GMP plasmid DNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthX Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Appletree CI
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Appletree CI
2.2 - Growth funds investing in similar companies to Appletree CI
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Appletree CI
4.2 - Public trading comparable groups for Appletree CI
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →